Categories
Topics

“Our proteins were used to develop a new COVID-19 serology test”

Deactivate selection mode Select images

The selection mode is now active. Click on the images you wish to download and choose an action below

Since the start of the COVID-19 pandemic, scientists at EPFL’s Protein Production and Structure Core Facility (PTPSP) have been producing and purifying SARS-CoV-2 proteins for use in Swiss research. Head of unit Dr. Florence Pojer Since the start of the COVID-19 pandemic, scientists at EPFL’s Protein Production and Structure Core Facility (PTPSP) have been producing and purifying SARS-CoV-2 proteins for use in Swiss research. Head of unit Dr. Florence Pojer Since the start of the COVID-19 pandemic, scientists at EPFL’s Protein Production and Structure Core Facility (PTPSP) have been producing and purifying SARS-CoV-2 proteins for use in Swiss research. Head of unit Dr. Florence Pojer Since the start of the COVID-19 pandemic, scientists at EPFL’s Protein Production and Structure Core Facility (PTPSP) have been producing and purifying SARS-CoV-2 proteins for use in Swiss research. Head of unit Dr. Florence Pojer Since the start of the COVID-19 pandemic, scientists at EPFL’s Protein Production and Structure Core Facility (PTPSP) have been producing and purifying SARS-CoV-2 proteins for use in Swiss research. Head of unit Dr. Florence Pojer Since the start of the COVID-19 pandemic, scientists at EPFL’s Protein Production and Structure Core Facility (PTPSP) have been producing and purifying SARS-CoV-2 proteins for use in Swiss research. Head of unit Dr. Florence Pojer